Overview of Dehydroepiandrosterone Biosynthesis

ABSTRACT

The biosynthesis of dehydroepiandrosterone (DHEA) from cholesterol involves only two enzymes, both cytochrome P450s. The conversion of cholesterol to pregnenolone is mediated by cholesterol side-chain cleavage enzyme (CYP11A1), which is found in the mitochondria. The cleavage of pregnenolone to DHEA requires both the 17α-hydroxylase and 17,20-lyase activities of CYP17, which is found in the endoplasmic reticulum. These conversions require pairs of electron transfer proteins or redox partners, which are adrenodoxin and adrenodoxin reductase for CYP11A1 and cytochrome P450-oxidoreductase and cytochrome b₅ for CYP17. In addition, the steroidogenic acute regulatory (StAR) protein regulates the flux of cholesterol into the biosynthetic pathway and represents the mechanism of acute regulation. Finally, in addition to possessing CYP11A1 and CYP17, it is equally important that a steroidogenic cell not contain other enzymes that drain the flux of pregnenolone to DHEA. These characteristics are illustrated by the fetal adrenal cortex and the zona reticularis, which are dedicated to the synthesis of DHEA and DHEA-sulfate.

KEYWORDS

Adrenal gland - dehydroepiandrosterone sulfate - CYP17 - 3β-hydroxysteroid dehydrogenase/Δ^5/4-isomerases - cytochrome b₅

REFERENCES

• 1 Gaunt R. History of the adrenal cortex. In: Greep RO, Astwood EB Handbook of Physiology: Endocrinology. Washington, DC; American Physiological Society 1975: 1
• 2 Baxter J D. Cortisone and the adrenal cortex. Trans Assoc Am Physicians 1987 100: clxvii
• 3 Simpson E R. Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis.  Mol Cell Endocrinol. 1979;  13 213-227
• 4 Clark B J, Wells J, King S R, Stocco D M. The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR).  J Biol Chem. 1994;  269 28314-28322
• 5 Stocco D M, Clark B J. Regulation of the acute production of steroids in steroidogenic cells.  Endocr Rev. 1996;  17 221-244
• 6 Tsujishita Y, Hurley J H. Structure and lipid transport mechanism of a StAR-related domain.  Nat Struct Biol. 2000;  7 408-414
• 7 Romanowski M J, Soccio R E, Breslow J L, Burley S K. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain.  Proc Natl Acad Sci USA. 2002;  99 6949-6954
• 8 Lin D, Sugawara T, Strauss III J F et al.. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis.  Science. 1995;  267 1828-1831
• 9 Bose H S, Sugawara T, Strauss III J F, Miller W L. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia.  N Engl J Med. 1996;  335 1870-1878
• 10 Caron K, Soo S-C, Wetsel W et al.. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia.  Proc Natl Acad Sci USA. 1997;  94 11540-11545
• 11 Miller W L, Strauss III J F. Molecular pathology and mechanism of action of the steroidogenic acute regulartory protein, StAR.  J Steroid Biochem Mol Biol. 1999;  69 131-141
• 12 Shimizu K, Gut M, Dorfman R I. 20α, 22α-dihydroxycholesterol, an intermediate in the biosynthesis of pregnonolone (3β-hydroxypregn-5-en-20-one) from cholesterol.  J Biol Chem. 1962;  237 699-702
• 13 Guryev O, Carvalho R A, Usanov S, Gilep A, Estabrook R W. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1).  Proc Natl Acad Sci USA. 2003;  100 14754-14759
• 14 Matteson K J, Chung B, Urdea M S, Miller W L. Study of cholesterol side chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes.  Endocrinology. 1986;  118 1296-1305
• 15 Chung B, Matteson K J, Voutilainen R, Mohandas T K, Miller W L. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta.  Proc Natl Acad Sci USA. 1986;  83 8962-8966
• 16 Matocha M, Waterman M R. Synthesis and processing of mitochondrial steroid hydroxylases. In vivo maturation of the precursor of cytochrome P450scc, cytochrome P45011ß, and adrenodoxin.  J Biol Chem. 1985;  260 12259-12265
• 17 Black S M, Harikrishna J A, Szklarz G D, Miller W L. The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme, cytochrome P450scc.  Proc Natl Acad Sci USA. 1994;  91 7247-7251
• 18 John M E, John M C, Boggaram V, Simpson E R, Waterman M R. Transcriptional regulation of steroid hydroxylase genes by corticotropin.  Proc Natl Acad Sci USA. 1986;  83 4715-4719
• 19 Mellon S H, Vaisse C. cAMP regulates P450scc gene expression by a cycloheximide-insensitive mechanism in cultured mouse leydig MA-10 cells.  Proc Natl Acad Sci USA. 1989;  86 7775-7779
• 20 Barrett P Q, Bollag W B, Isales C M, McCarthy R T, Rasmussen H. The role of calcium in angiotensin II-mediated aldosterone secretion.  Endocr Rev. 1989;  10 496-518
• 21 Yang X, Iwamoto K, Wang M et al.. Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme.  Endocrinology. 1993;  132 1977-1982
• 22 Hu M C, Hsu N C, El Hadj N B et al.. Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1.  Mol Endocrinol. 2002;  16 1943-1950
• 23 Tajima T, Fujieda K, Kouda N, Nakae J, Miller W L. Heterozygous mutation in the cholesterol side chain cleavage enzyme (P450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency.  J Clin Endocrinol Metab. 2001;  86 3820-3825
• 24 Kimura T, Suzuki K. Components of the electron transport system in adrenal steroid hydroxylase. Isolation and properties of non-heme iron protein(adrenodoxin).  J Biol Chem. 1967;  242 485-491
• 25 Vickery L E. Molecular recognition and electron transfer in mitochondrial steroid hydroxylase systems.  Steroids. 1997;  62 124-127
• 26 Geren L M, O'Brien P, Stonehuerner J, Millett F. Identification of specific carboxylate groups on adrenodoxin that are involved in the interaction with adrenodoxin reductase.  J Biol Chem. 1984;  259 2155-2160
• 27 Coghlan V M, Vickery L E. Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc.  J Biol Chem. 1991;  266 18606-18612
• 28 Zuber M X, Simpson E R, Waterman M R. Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS-1) cells.  Science. 1986;  234 1258-1261
• 29 Chung B C, Picado-Leonard J, Haniu M et al.. Cytochrome P450c17 (steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues.  Proc Natl Acad Sci USA. 1987;  84 407-411
• 30 Lund J, Ahlgren R, Wu D et al.. Transcriptional regulation of the bovine CYP17 (P-45017α) gene.  J Biol Chem. 1990;  265 3304-3312
• 31 Waterman M R, Simpson E R. Regulation of steroid hydroxylase gene expression is multifactorial in nature.  Recent Prog Horm Res. 1989;  45 533-566
• 32 Lin C J, Martens J W, Miller W L. NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells.  Mol Endocrinol. 2001;  15 1277-1293
• 33 Yasukochi Y, Masters B S. Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography.  J Biol Chem. 1976;  251 5337-5344
• 34 Lee-Robichaud P, Wright J N, Akhtar M E, Akhtar M. Modulation of the activity of human 17α-hydroxylase-17,20-lyase (CYP17) by cytochrome b₅: endocrinological and mechanistic implications.  Biochem J. 1995;  308 901-908
• 35 Auchus R J, Lee T C, Miller W L. Cytochrome b₅ augments the 17,20 lyase activity of human P450c17 without direct electron transfer.  J Biol Chem. 1998;  273 3158-3165
• 36 Flück C E, Miller W L, Auchus R J. The 17,20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ⁵ steroidogenic pathway.  J Clin Endocrinol Metab. 2003;  88 3762-3766
• 37 Swart P, Swart A C, Waterman M R, Estabrook R W, Mason J I. Progesterone 16α-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase.  J Clin Endocrinol Metab. 1993;  77 98-102
• 38 Onoda M, Hall P F. Cytochrome b₅ stimulates purified testicular microsomal cytochrome P450 (C₂₁ side-chain cleavage).  Biochem Biophys Res Commun. 1982;  108 454-460
• 39 Katagiri M, Kagawa N, Waterman M R. The role of cytochrome b₅ in the biosynthesis of androgens by human P450c17.  Arch Biochem Biophys. 1995;  317 343-347
• 40 Nakajin S, Takahashi M, Shinoda M, Hall P F. Cytochrome b₅ promotes the synthesis of Δ¹⁶-C₁₉ steroids by homogeneous cytochrome P-450 C21 side-chain cleavage from pig testis.  Biochem Biophys Res Commun. 1985;  132 708-713
• 41 Gupta M K, Guryev O L, Auchus R J. 5α-reduced C21 steroids are substrates for human cytochrome P450c17.  Arch Biochem Biophys. 2003;  418 151-160
• 42 Lee T C, Miller W L, Auchus R J. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes.  J Clin Endocrinol Metab. 1999;  84 2104-2110
• 43 Auchus R J, Kumar A S, Boswell C A et al.. The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21.  Arch Biochem Biophys. 2003;  409 134-144
• 44 Arlt W, Auchus R J, Miller W L. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase.  J Biol Chem. 2001;  276 16767-16771
• 45 Zhang L, Rodriguez H, Ohno S, Miller W L. Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and for the polycystic ovary syndrome.  Proc Natl Acad Sci USA. 1995;  92 10619-10623
• 46 Pandey A V, Mellon S H, Miller W L. Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17.  J Biol Chem. 2003;  278 2837-2844
• 47 Auchus R J. The genetics, pathophysiology, and management of human deficiencies of P450c17.  Endocrinol Metab Clin North Am. 2001;  30 101-119
• 48 Biglieri E G, Herron M A, Brust N. 17α-hydroxylation deficiency in man.  J Clin Invest. 1966;  45 1945-1954
• 49 Costa-Santos M, Kater C E, Auchus R J. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.  J Clin Endocrinol Metab. 2004;  89 49-60
• 50 Geller D H, Auchus R J, Mendonça B B, Miller W L. The genetic and functional basis of isolated 17,20 lyase deficiency.  Nat Genet. 1997;  17 201-205
• 51 Van Den Akker E L, Koper J W, Boehmer A L et al.. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.  J Clin Endocrinol Metab. 2002;  87 5714-5721
• 52 Geller D H, Auchus R J, Miller W L. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b₅ .  Mol Endocrinol. 1999;  13 167-175
• 53 Auchus R J, Miller W L. Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.  Mol Endocrinol. 1999;  13 1169-1182
• 54 Sherbet D P, Tiosano D, Kwist K M, Hochberg Z. Auchus RJ. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.  J Biol Chem. 2003;  278 48563-48569
• 55 Rhéaume E, Lachance Y, Zhao H L et al.. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ⁵-Δ⁴-isomerase in human adrenals and gonads.  Mol Endocrinol. 1991;  5 1147-1157
• 56 Thomas J L, Myers R P, Strickler R C. Human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5/4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes.  J Steroid Biochem. 1989;  33 209-217
• 57 Bongiovanni A M. The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase.  J Clin Invest. 1962;  41 2086-2092
• 58 Moisan A M, Ricketts M L, Tardy V et al.. New insight into the molecular basis of 3β-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3β2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.  J Clin Endocrinol Metab. 1999;  84 4410-4425
• 59 Lachance Y, Luu-The V, Labrie F et al.. Characterization of human 3β-hydroxysteroid dehydrogenase/Δ⁵-Δ⁴-isomerase gene and its expression in mammalian cells.  J Biol Chem. 1990;  265 20469-20475
• 60 White P C, Speiser P W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  Endocr Rev. 2000;  21 245-291
• 61 Yuen B H, Mincey E K. Human chorionic gonadotropin, prolactin, estriol, and dehydroepiandrosterone sulfate concentrations in cord blood of premature and term newborn infants: relationship to the sex of the neonate.  Am J Obstet Gynecol. 1987;  156 396-400
• 62 Miller W L. Steroid hormone biosynthesis and actions in the materno-feto-placental unit.  Clin Perinatol. 1998;  25 799-817
• 63 de Peretti E, Pradon M, Forest M G. 17,20-desmolase deficiency in a female newborn, paradoxically virilized in utero.  J Steroid Biochem. 1984;  20 455-458
• 64 Smith M R, Rudd B T, Shirley A et al. A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulphate in normal and pathological sera.  Clin Chim Acta. 1975;  65 5-13
• 65 Orentreich N, Brind J L, Rizer R L, Vogelman J H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.  J Clin Endocrinol Metab. 1984;  59 551-555
• 66 Auchus R J, Rainey W E. Adrenarche-physiology, biochemistry and human disease.  Clin Endocrinol (Oxf). 2004;  60 288-296
• 67 Suzuki T, Sasano H, Takeyama J et al.. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies.  Clin Endocrinol (Oxf). 2000;  53 739-747
• 68 Mapes S, Corbin C, Tarantal A, Conley A. The primate adrenal zona reticularis is defined by expression of cytochrome b₅, 17α-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3β-hydroxysteroid dehydrogenase/Δ5-4 isomerase (3β-HSD).  J Clin Endocrinol Metab. 1999;  84 3382-3385
• 69 Dardis A, Saraco N, Rivarola M A, Belgorosky A. Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: Implications for the mechanism of adrenarche.  Pediatr Res. 1999;  45 384-388
• 70 Forbes K J, Hagen M, Glatt H, Hume  R, Coughtrie M W. Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme.  Mol Cell Endocrinol. 1995;  112 53-60